Replies to post #389550 on Elite Pharmaceuticals Inc (ELTP)

[The ELTP King]

50/50 we get news Monday.

10-month deadline for Dopamine Agonist is Sunday which probably means the FDA has until Monday to decide.

And then Elite is conservative with their announcements.

They usually wait until it's posted on the FDA's website.

Bottom line as stated earlier, the following press releases WILL be issued on or before November 15, 2023:

1. Elite Pharmaceuticals Receives FDA Approval for Dopamine Agonist

2. Elite Pharmaceuticals Files ANDA with US FDA to Market CNS Stimulant

3. Elite Pharmaceuticals Reports Record Revenues for Second Quarter of Fiscal Year 2024

Monday News will decide that